Results per Page:
New grant funds research on circadian disruption and its potential link to liver cancer
In this episode of From Bench to Bedside and Beyond, Dr. Trang VoPham talks about her research into solar jet lag, including how it can impact your health
Does solar jet lag contribute to liver cancer?
Fred Hutch researcher will use American Cancer Society grant to determine if circadian disruption increases risk for hepatocellular carcinoma
Fred Hutch brings together rare cancer community
Patients and caregivers share frustrations, practical realities of rare cancer life at TRACER program’s first education symposium
Can you get a cancer screening without insurance?
Uninsured? Underinsured? Mammograms and other preventive cancer screenings are still available
What’s the psychology behind using dietary supplements?
In this episode of From Bench to Bedside and Beyond, Dr. Jonathan Bricker explains why we choose the ‘quick fix’ over tried-and-true cancer prevention methods
Supplements don’t prevent cancer, studies show
Fred Hutch research finds some supplements offer little benefit, some may increase cancer risk and some can interfere with treatment
Cancer Action Plan of Washington (CAPOW) packs a punch
New 5-year plan maps out key strategies to reduce cancer rates, deaths by boosting health literacy, screening, prevention and equity efforts
Getting the best bang for your cancer prevention buck
Fred Hutch experts weigh in on budget-friendly ways to cut disease risk and stay healthy in the new year
SABCS25: What’s new in breast cancer research?
Advances include a new endocrine therapy, the use of ctDNA to predict response and modifying PET/CTs to better track bone metastases
Breast Cancer Research Foundation to fund seven Cancer Consortium researchers
BCRF awards $2.6M in grants to Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium researchers
Value in Cancer Care Summit reimagines cancer care
Annual conference zeroes in on practical solutions for patient and provider pain points like burnout, symptom management and financial toxicity
Washington Research Foundation awards $5.2M to establish new clinical trials program
Funds will help develop ‘first-in-human’ trials for new therapeutics invented at Fred Hutch and Seattle Children’s
Lack of insurance, follow-ups undercut cancer screening wins
Large multi-institution PROSPR II study finds big gaps in access, timely care in cervical, colorectal and lung cancers across U.S.
Patient stories, provider advice mark invasive lobular breast cancer awareness event
Fred Hutch experts discuss ILC’s hormonal risk factors, screening recommendations and new research
Lived experience matters: patient engagement improves cancer care, research
Nearly 15 years in, Fred Hutch Patient and Family Engagement Program continues to inform care, expands to match advocates with researchers
Testing for hereditary cancers can be a lifesaver
Some people aren’t ready yet, while others believe ‘forewarned is forearmed’ when it comes to cancer-causing genetic variants
Are we ready for multi-cancer detection tests?
Blood-based cancer tests are coming, but questions about efficacy, reimbursement and diagnostic pathways are far from settled
Biomarkers, tumor markers and tumor boards: What cancer patients need to know
Cancer care is changing — as are the clinical tools, tests and the terms used to diagnose and predict its path and treatment
How do you measure your health? WHI comes up with two potent indicators
New studies using Women’s Health Initiative data highlight new ‘biomarkers’ to predict mortality risk and guide providers' care
Women’s Health Initiative: Research that keeps on giving
Three decades in, longstanding ‘team science’ study continues to provide answers to health issues facing older women